The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington’s disease

Medicine and Dentistry

• Huntington's Disease 75%
• In Vitro 25%
• Cresyl Violet 25%
• Drug Therapy 25%
• Motor Activity 25%
• Methyl Cellulose 25%
• Ventricle of Heart 25%
• Therapy Effect 25%
• Nerve Growth Factor 25%
• Motor Coordination 25%
• Age 25%
• Examination 25%
• Therapeutic Procedure 25%
• Female 25%
• Assessment 25%
• Tail 25%
• Limb 25%
• Torso 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse 100%
• Huntington Chorea 75%
• Mouse Model 50%
• Pyrimidine 50%
• Transgenic Mouse 50%
• Nerve Growth Factor 25%
• Intubation 25%
• Methylcellulose 25%

Neuroscience

• Huntington's Disease 75%
• Pyrimidine 50%
• Brain 50%
• In Vitro 25%
• Cresyl Violet 25%
• Methyl Cellulose 25%
• Nerve Growth Factor 25%
• Motor Coordination 25%